Literature DB >> 2297228

Tetrameric structure of mitochondrially bound rat brain hexokinase: a crosslinking study.

G Xie1, J E Wilson.   

Abstract

Rat brain hexokinase (ATP:D-hexose-6-phosphotransferase; EC 2.7.1.1) was derivatized with sulfosuccinimidyl-2-(m-azido-o-nitrobenzamido)ethyl-1,3'-dithiopro pionate (SAND), a photosensitive and cleavable crosslinking agent. The catalytic activity and mitochondrial binding properties of the enzyme were only marginally affected by reaction with SAND. When the derivatized enzyme was bound to liver mitochondria, photolysis resulted in extensive formation of a single crosslinked species with estimated molecular mass 460 kDa. This was determined to contain only hexokinase and thus represents a tetramer of the 116 kDa (apparent molecular mass in gel system used) monomeric enzyme. Although small amounts of tetramer were detected after photolysis of relatively high concentrations of derivatized enzyme in free solution, tetramer formation was greatly enhanced when the enzyme was bound to mitochondria. No evidence of dimeric or trimeric structures was seen even when only a small fraction of the available binding sites on the mitochondrial membrane were occupied. It is thus concluded that tetramer formation is closely linked with binding of the enzyme to the outer mitochondrial membrane and, more specifically, to the pore structure through which metabolites traverse this membrane. It is speculated that a tetrameric structure surrounding the mitochondrial pores may facilitate interactions between the hexokinase reaction and oxidative phosphorylation, mediated by the adenine nucleotides which are common intermediates in these reactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297228     DOI: 10.1016/0003-9861(90)90040-6

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  17 in total

1.  Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria.

Authors:  Ran Zalk; Adrian Israelson; Erez S Garty; Heftsi Azoulay-Zohar; Varda Shoshan-Barmatz
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

2.  Binding of rat brain hexokinase to recombinant yeast mitochondria: effect of environmental factors and the source of porin.

Authors:  C Aflalo; H Azoulay
Journal:  J Bioenerg Biomembr       Date:  1998-06       Impact factor: 2.945

3.  Binding of rat brain hexokinase to recombinant yeast mitochondria: identification of necessary molecular determinants.

Authors:  H Azoulay-Zohar; C Aflalo
Journal:  J Bioenerg Biomembr       Date:  1999-12       Impact factor: 2.945

4.  Hexokinase 'binding sites' of normal and tumoral human brain mitochondria.

Authors:  A Golestani; M Nemat-Gorgani
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

Review 5.  Mitochondrial and postmitochondrial survival signaling in cancer.

Authors:  Neelu Yadav; Dhyan Chandra
Journal:  Mitochondrion       Date:  2013-12-10       Impact factor: 4.160

Review 6.  The importance of the outer mitochondrial compartment in regulation of energy metabolism.

Authors:  D Brdiczka; T Wallimann
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

7.  VDAC and peripheral channelling complexes in health and disease.

Authors:  Mikhail Vyssokikh; Dieter Brdiczka
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

8.  In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death.

Authors:  Heftsi Azoulay-Zohar; Adrian Israelson; Salah Abu-Hamad; Varda Shoshan-Barmatz
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

9.  The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death.

Authors:  Syed Mohammad Moin; Milena Panteva; Shahid Jameel
Journal:  J Biol Chem       Date:  2007-05-08       Impact factor: 5.157

Review 10.  Regulation of hexokinase binding to VDAC.

Authors:  John G Pastorino; Jan B Hoek
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.